EMUC25 special: Dr. Rescigno talks about single agent TKI in selected mRCC patients
EAU Podcasts18 Marras 2025

EMUC25 special: Dr. Rescigno talks about single agent TKI in selected mRCC patients

UROONCO RCC associate editor Assoc. Prof. Carlotta Palumbo (IT) talks with medical oncologist Dr. Pasquale Rescigno (GB) about his presentation supporting the 'yes' position in the debate at EMUC25: “Is single agent TKI (tyrosine kinase inhibitor) still an option in selected mRCC patients? This interview was recorded at EMUC25 in Prague. For more updates on kidney cancer, please visit our educational platform UROONCO RCC. For more EAU podcasts, please go to your favourite podcast app an...

Jaksot(209)

Prof. Christian Radmayr about management of undescended testes

Prof. Christian Radmayr about management of undescended testes

In this episode, Prof. Christian Radmayr shares his expert insights in treating undescended testes covering topics such as: Frequency of undescended testes among boysReasons for its occurrenceHow to c...

30 Syys 202114min

Dr. Stefanie Fischer discussing the adjuvant treatment of Stage 1 testicular cancer

Dr. Stefanie Fischer discussing the adjuvant treatment of Stage 1 testicular cancer

What are the recommendations for the management of stage I seminoma and stage I non-seminoma after orchiectomy? Tune in as Dr. Stefanie Fischer provides vital information on this, as well as, the risk...

30 Syys 202110min

Prof. Bhaskar Somani offers tips in publishing scientific papers

Prof. Bhaskar Somani offers tips in publishing scientific papers

With over 400 peer-reviewed papers published, Prof. Bhaskar Somani is an editorial board member of 4 journals and a reviewer for 15 journals. In this episode, he shares his experience in publishing sc...

30 Syys 202112min

Prof. Nicolas Mottet on new guideline recommendations for prostate cancer part 1

Prof. Nicolas Mottet on new guideline recommendations for prostate cancer part 1

In this first part, Prof. Nicolas Mottet talks about the most important changes in the new EAU Guidelines for Prostate Cancer treatment and discusses in more detail perineal biopsy, staging PSMA, adju...

30 Syys 202114min

Prof. Nicolas Mottet on new guideline recommendations for prostate cancer part 2

Prof. Nicolas Mottet on new guideline recommendations for prostate cancer part 2

In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant pr...

30 Syys 202113min

Dr. Paolo Capogrosso discussing what is new in the field of male infertility

Dr. Paolo Capogrosso discussing what is new in the field of male infertility

Data has shown the prevalence of infertility has increased over the last decades. In this episode, Dr. Paolo Capogrosso explores if this is also the case in males. Dr. Capogrosso discusses: Any novel ...

30 Syys 202112min

Prof. Paolo Gontero on Risk Stratification for Non-Muscle Invasive Bladder Cancer

Prof. Paolo Gontero on Risk Stratification for Non-Muscle Invasive Bladder Cancer

Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have...

30 Syys 202116min

Why should we make a podcast?

Why should we make a podcast?

Welcome to the EAU Podcast. In this episode, we have compiled some useful background information on why the EAU is branching out into podcasting, how it will engage listeners, and reach new audiences.

30 Syys 20213min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rahapuhetta
rss-rahamania
kesken
psykologia
rss-liian-kuuma-peruna
rss-niinku-asia-on
rss-eron-alkemiaa
rss-arkea-ja-aurinkoa-podcast-espanjasta
esa-saarinen-filosofia-ja-systeemiajattelu
rss-duodecim-lehti
rss-vapaudu-voimaasi
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
rss-finnish-daily-dialogues
ihminen-tavattavissa-tommy-hellsten-instituutti